Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Etex has launched EquivaBone, a bone graft substitute that remodels and is replaced with new bone during the healing process.
Subscribe to our email newsletter
EquivaBone is a proprietary combination of osteoinductive demineralized bone matrix (DBM) and Etex’s osteoconductive nanocrystalline calcium phosphate.
EquivaBone is intended for use in filling bone voids or defects of the skeletal system (including extremities, pelvis, and spine) that are not intrinsic to the stability of the bone structure. Etex will market EquivaBone through its direct distribution channel.
Brian Ennis, president and CEO of Etex, said: “Etex is excited to offer surgeons a best-in-class combination product that provides optimal osteoinductive and osteoconductive performance.
“This product is the culmination of years of research and development. Based on initial customer feedback, we anticipate a robust market response.”